Evidence map›Paper›PMID 25630499›Full record

ArticleBioorganic & medicinal chemistry2015

MCR synthesis of a tetracyclic tetrazole scaffold.

Pravin Patil, Kareem Khoury, Eberhardt Herdtweck, Alexander Dömling

Abstract read
In one paragraph

Article in Bioorganic & medicinal chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. The Pictet-Spengler Reaction Updates Its Habits.Molecules (Basel, Switzerland) · 2020
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. α-Amino Acid-Isosteric α-Amino Tetrazoles.Chemistry (Weinheim an der Bergstrasse, Germany) · 2016
    Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Pravin PatilDepartment of Drug Design, University of Groningen, A. Deusinglaan 1, Groningen 9700 AD, The Netherlands.
Kareem KhouryCarmolex Inc., Pittsburgh, USA.
Eberhardt HerdtweckTechnische Universität München, Germany.
Alexander DömlingDepartment of Drug Design, University of Groningen, A. Deusinglaan 1, Groningen 9700 AD, The Netherlands. Electronic address: a.s.s.domling@rug.nl.

Funding

Real-time discovery of inhibitors among billion compounds for preview and downloadR01GM097082 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CAMACHO, CARLOS J. · 2011 to 2020
$2.5M
NIGMS NIH HHS 1R01GM097082-01NIGMS NIH HHS R01 GM097082
6 · The paper itself

Abstract

Scaffold diversity is key in the ongoing exercise of discovery of novel bioactive compounds using high throughput screening (HTS). Based on the Ugi tetrazole synthesis we have designed novel bi- and tri-cyclic scaffolds featuring interesting pharmacophore properties. The compounds of the scaffold (B) are synthesizable in large diversity and numbers in two steps using (hetero)phenylethylamines, HN3, oxo components and iscyanoacetaldehyde(dimethylacetale). The chemistry is amenable to parallel synthesis and is used to enhance and fill the screening decks of the European Lead factory (ELF). Here, we are reporting full experimental details, scope and limitations of the reaction, cheminformatic analysis and the 3D structures of selected compounds.

Indexed as

Drug DiscoveryModels, MolecularMolecular StructurePolycyclic CompoundsTetrazolesPolycyclic CompoundsTetrazolesIsocyanideParallelPictet–SpenglerSynthesisTetrazolUgi

Identifiers

PMID25630499
PMCPMC4733496

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.